Edition:
United States

Biotechnology & Medical Research

Page 1

Coherus Biosciences files for offering of upto 6.56 million shares of common stock by the selling stockholder‍​

Friday, 22 Sep 2017 05:35pm EDT

Sept 22 (Reuters) - Coherus Biosciences Inc :Coherus Biosciences Inc - Files for offering of upto 6.56 million shares of common stock by the selling stockholder‍​ - SEC filing.

Auris Medical completes patient recruitment for phase 3 trial of Keyzilen in acute and post-acute tinnitus

Friday, 22 Sep 2017 08:00am EDT

Sept 22 (Reuters) - Auris Medical Holding Ag :Auris Medical completes patient recruitment for phase 3 TACTT3 trial of Keyzilen in acute and post-acute tinnitus.Auris Medical Holding Ag - ‍top-line results from TACTT3 trial are expected in Q1 of 2018​.

Avista Capital Partners to acquire Miraca Life Sciences

Friday, 22 Sep 2017 07:00am EDT

Sept 22 (Reuters) - Avista Capital Ii [RIC:RIC:AVAAA.UL]:Avista Capital Partners says ‍Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc​.

Miraca Holdings says change of unit

Friday, 22 Sep 2017 05:28am EDT

Sept 22 (Reuters) - Miraca Holdings Inc <4544.T>:Says co's unit Miraca Life Sciences Inc's parent company CDx Holdings Inc (CDx) will merge with Avista Capital Holdings LP's unit Symphony Merger Sub Inc (Merger Sub) to become one company (CDx & Merger Sub).Says co will hold 15 percent stake in new holding company Symphony Buyer Inc, which will indirectly hold 100 percent in CDx & Merger Sub.Says co will cut all stake in unit Miraca Life Sciences Inc after the merger in November .Says transaction amount is $175.6 million .

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary